Familial combined hyperlipidemia
Familial combined hyperlipidemia (FCH) is an independent disease first recognized in 1973. This type of dyslipidemia is most common in patients with coronary heart disease under the age of 60. Other studies have shown that FCH is the most common type of dyslipidemia in patients over the age of 40 with unexplained ischemic stroke.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Patients under 60 years of age with coronary heart disease -
Related symptoms:
Abnormal blood lipids diabetes high blood pressure obesity high blood pressure -
Concurrent disease:
Related Drugs
Lovastatin Tablets
Indication: Used to treat hypercholesterolemia and combined hyperlipidemia.
Manufacturer:
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Simvastatin Capsules
Indication: Used for the treatment of hypercholesterolemia and combined hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.
Manufacturer:
Hubei Shubang Pharmaceutical Co., Ltd.
Bezafibrate Tablets
Indication: Used to treat hypertriglyceridemia, hypercholesterolemia, and combined hyperlipidemia.
Manufacturer:
Jiangsu Kanion Pharmaceutical Co., Ltd.
Related Ingredients